Transaction Terms
Subject to the terms and conditions of the merger agreements, CCIT II, CCIT III and CCPT V stockholders would receive, for each share of common stock of the relevant entity held by them, 1.501,1.093 and 2.691 shares, respectively, of CMFT common stock, which is valued at approximately $10.97 per CCIT II share, $7.99 per CCIT III share and $19.67 per CCPT V share, based on CMFT’s most recently estimated net asset value per share of $7.31.
Following the closings of the merger transactions, former stockholders of CMFT, CCIT II, CCIT III and CCPT V are expected to own approximately 67%, 22%, 1% and 10% of CC CMFT, respectively. Upon closing, the Board of Directors of CC CMFT will be increased so that all independent directors of CCIT II, CCIT III and CCPT V that are not currently independent directors of CMFT will be added to the Board. It is anticipated that at the next CMFT annual stockholder meeting, 5 to 7 directors will be recommended for election.
The distribution reinvestment plans of CMFT, CCIT II, CCIT III and CCPT V will be suspended pending the closing of the proposed transactions. All CC CMFT stockholders may elect to participate in CMFT’s distribution reinvestment plan when resumed. The Board of Directors of each of CMFT, CCIT II, CCIT III and CCPT V will continue to make a determination on a monthly basis regarding the declaration of a monthly distribution until the closing of the transactions. It is anticipated that CC CMFT will continue to provide a sustainable distribution to stockholders following closing, subject to the approval of its Board of Directors, market factors and company performance.
The merger agreements provide each of CCIT II, CCIT III and CCPT V with a go-shop period of 38 days. During such period, the special committee of the Board of Directors of each of CCIT II, CCIT III and CCPT V intends to actively solicit alternative acquisition proposals from third parties. Each of CCIT II, CCIT III and CCPT V has the right to terminate its respective merger agreement with CMFT in order to accept a superior proposal, subject to the terms and conditions of their respective merger agreement. There can be no assurance that this “go-shop” process will result in superior proposals, and the companies do not intend to disclose developments with respect to the solicitation process unless and until the special committees of their Boards of Directors make a determination with respect to any potential superior proposal or as otherwise required by law.
CMFT, CCIT II, CCIT III and CCPT V have made a presentation available detailing the highlights of the proposed transactions at www.cimgroup.com/announcements.
Advisors
Barclays is acting as financial advisor to the Special Committee of the Board of Directors of CMFT, and Sullivan & Cromwell LLP and Venable LLP are acting as legal advisors to the Special Committee of the Board of Directors of CMFT. Morris, Manning & Martin, LLP is acting as REIT and securities counsel in connection with the transactions. The Special Committees of the Boards of Directors of CCIT II, CCIT III and CCPT V have engaged Truist Securities, Robert A. Stanger & Co., Inc., and HFF Securities, L.P., a JLL company, respectively, as their financial advisors, and Latham & Watkins LLP, Miles & Stockbridge P.C. and Goodwin Procter LLP, respectively, as their legal advisors.